8-K: Patterson Companies Acquired by Patient Square Capital, Appoints Robert Rajalingam as CEO

Patterson Companies, a leading supplier in the dental and animal health markets, has been acquired by Patient Square Capital, leading to Robert Rajalingam's appointment as the new CEO, effective April 17, 2025.

Summary

• Patterson Companies has been acquired by Patient Square Capital on April 17, 2025.
• Robert Rajalingam has been appointed as the new CEO, effective April 17, 2025.
• Former CEO Don Zurbay will retire but will support the company on a transitional basis.
• Rajalingam has over 25 years of experience in healthcare management, most recently as President of Cardinal Health's U.S. Medical Products and Distribution business.
• Patient Square Capital had approximately $12 billion in assets under management as of December 31, 2024.
• Patterson Companies will maintain its headquarters in St. Paul, Minnesota.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the completion of the acquisition and the appointment of a new CEO with significant experience. The management comments are optimistic about the future.

Positives

• The acquisition by Patient Square Capital is expected to help Patterson Companies reach its full potential.
• Robert Rajalingam's extensive experience in healthcare management is seen as a positive for the company's future growth.
• Patient Square Capital's investment indicates confidence in Patterson's business model and future prospects.
• The company will maintain its headquarters in St. Paul, Minnesota.

Negatives

• Don Zurbay is retiring from his role as CEO.
• Patterson's common stock is no longer traded on the NASDAQ Global Select Market.

Risks

• The transition to a new CEO and ownership structure could present challenges.
• Integrating Patterson Companies into Patient Square Capital's portfolio may require adjustments.
• The company faces potential risks related to market competition and economic conditions.

Future Outlook

Patient Square Capital believes Patterson is well-positioned to live up to its potential while building on its proud legacy. Robert Rajalingam looks forward to working closely with the Patient Square team and the talented employees of Patterson to enhance their offerings, strengthen partnerships, and deliver exceptional value to customers.

Management Comments

• Robert Rajalingam: 'I am honored to join Patterson Companies at this pivotal time. The company has a strong foundation and an unwavering commitment to serving its dental and animal health customers.'
• Don Zurbay: 'I am proud of the Patterson team and everything that we have accomplished over the last several years and believe that this transaction and Robert's leadership will help drive the business to new heights.'
• Justin Sabet-Peyman: 'With the completion of this acquisition, we are confident that Patterson is well-positioned to live up to its potential while building on its proud legacy.'

Industry Context

The acquisition reflects the ongoing trend of private equity firms investing in healthcare companies, particularly those with strong market positions and growth potential in specialized sectors like dental and animal health.

Comparison to Industry Standards

• Cardinal Health, where Robert Rajalingam previously served, is a major player in medical products and distribution, similar to Patterson's role in dental and animal health.
• Patient Square Capital's $12 billion in assets under management places it among the larger healthcare-focused private equity firms, comparable to firms like KKR Health Care Strategic Growth and Blackstone Life Sciences.
• The acquisition of Patterson Companies is similar to other private equity deals in the healthcare distribution space, such as the acquisition of Medline Industries by a consortium of private equity firms.

Management Changes

Stakeholder Impact

• Shareholders: The acquisition results in Patterson's common stock no longer being traded on the NASDAQ Global Select Market.
• Employees: The company will maintain its headquarters in St. Paul, Minnesota, suggesting no immediate plans for significant workforce changes.
• Customers: The new CEO aims to enhance offerings and strengthen partnerships to deliver exceptional value to customers.

Next Steps

• Robert Rajalingam will assume his role as CEO and work with the Patient Square team to enhance Patterson's offerings.
• Don Zurbay will support the company on a transitional basis.
• Patterson Companies will continue to operate from its headquarters in St. Paul, Minnesota.

Key Dates

Keywords

Patterson Companies, Patient Square Capital, acquisition, Robert Rajalingam, CEO, Don Zurbay, healthcare, dental, animal health